Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : AstaReal
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Supplementation of Astaxanthin on Skin Photoaging, Hydration and Elasticity
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 31, 2023
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : AstaReal
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lutein,Astaxanthin
Therapeutic Area : Ophthalmology
Study Phase : Preclinical
Sponsor : LY Research Corporation
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : The agreement aims to market a patented product for Eye Health due to Myopia and Presbyopia. This Patent is a liposome and sustained release polymeric micelles preparation that improves the solubility of lutein.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Undisclosed
March 30, 2023
Lead Product(s) : Lutein,Astaxanthin
Therapeutic Area : Ophthalmology
Highest Development Status : Preclinical
Sponsor : LY Research Corporation
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Lead Product(s) : Chaga Mushroom,Algae Extract,Black Cumin Seed,Astaxanthin,Omega 3
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Natural Modulators of Immune Function and Mood
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 19, 2022
Lead Product(s) : Chaga Mushroom,Algae Extract,Black Cumin Seed,Astaxanthin,Omega 3
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : LycoRed Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Astaxanthin, Exercise Inflammation, Skin Health
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 08, 2022
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : LycoRed Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Nutrasource
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate the Effect of Astaxanthin in Healthy Participants
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 17, 2022
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Nutrasource
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Musculoskeletal
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Astaxanthin for Management of Inflammation in Knee Osteoarthritis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 01, 2021
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Neurology
Study Phase : Phase II/ Phase III
Sponsor : PT SOHO Global Health Tbk
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 30, 2020
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Phase II/ Phase III
Sponsor : PT SOHO Global Health Tbk
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Pharmacokinetics of Phaffia Rhodozyma Astaxanthin
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 16, 2019
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Astaxanthin,Lycopene,Vitamin E
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 09, 2018
Lead Product(s) : Astaxanthin,Lycopene,Vitamin E
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioavailability of Astaxanthin Formulations
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 23, 2018
Lead Product(s) : Astaxanthin,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable